BRPI0513702A - comprimidos revestidos gelatinosos que se desintegram rapidamente - Google Patents

comprimidos revestidos gelatinosos que se desintegram rapidamente

Info

Publication number
BRPI0513702A
BRPI0513702A BRPI0513702-0A BRPI0513702A BRPI0513702A BR PI0513702 A BRPI0513702 A BR PI0513702A BR PI0513702 A BRPI0513702 A BR PI0513702A BR PI0513702 A BRPI0513702 A BR PI0513702A
Authority
BR
Brazil
Prior art keywords
gelatin coated
coated tablets
rapidly disintegrating
relates
gelatin
Prior art date
Application number
BRPI0513702-0A
Other languages
English (en)
Inventor
Roger A Rinker
Nicholas J Casale
James H Comly
Brenda Pollock
Atul D Ayer
Johan Geerke
Martin Costello
Dennis Wieand
Kishor Parekh
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34960790&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0513702(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of BRPI0513702A publication Critical patent/BRPI0513702A/pt
Publication of BRPI0513702B1 publication Critical patent/BRPI0513702B1/pt
Publication of BRPI0513702B8 publication Critical patent/BRPI0513702B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2873—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Catalysts (AREA)
  • Gears, Cams (AREA)

Abstract

COMPRIMIDOS REVESTIDOS GELATINOSOS QUE SE DESINTEGRAM RAPIDAMENTE. A presente invenção refere-se a uma forma de dosagem com revestimento gelatinoso aperfeiçoado que apresenta duas regiões finais revestidas com materiais gelatinosos e uma faixa circunferente exposta. São proporcionadas aberturas pelo menos na faixa exposta para revelar o material de núcleo. A invenção também refere-se a métodos para produzir essas formas de dosagem com revestimento gelatinoso.
BRPI0513702A 2004-07-23 2005-02-16 formas de dosagem e métodos para produção das mesmas BRPI0513702B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/898,061 US8067029B2 (en) 2004-01-13 2004-07-23 Rapidly disintegrating gelatinous coated tablets
US10/898,061 2004-07-23
PCT/US2005/001075 WO2006022805A1 (en) 2004-07-23 2005-02-16 Rapidly disintegrating gelatinous coated tablets

Publications (3)

Publication Number Publication Date
BRPI0513702A true BRPI0513702A (pt) 2008-05-13
BRPI0513702B1 BRPI0513702B1 (pt) 2020-02-18
BRPI0513702B8 BRPI0513702B8 (pt) 2022-08-30

Family

ID=34960790

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0513702A BRPI0513702B8 (pt) 2004-07-23 2005-02-16 formas de dosagem e métodos para produção das mesmas

Country Status (14)

Country Link
US (1) US8067029B2 (pt)
EP (2) EP1773302B2 (pt)
KR (1) KR101140599B1 (pt)
CN (1) CN1913877B (pt)
AT (1) ATE433319T1 (pt)
BR (1) BRPI0513702B8 (pt)
CA (1) CA2553444C (pt)
DE (1) DE602005014874D1 (pt)
DK (1) DK1773302T3 (pt)
ES (2) ES2326671T3 (pt)
MX (1) MXPA06008307A (pt)
PL (1) PL1773302T3 (pt)
RU (1) RU2367413C2 (pt)
WO (1) WO2006022805A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040253312A1 (en) * 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
US8067029B2 (en) 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US7879354B2 (en) * 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US20070009573A1 (en) * 2005-07-07 2007-01-11 L N K International Method of forming immediate release dosage form
EP2433621B1 (en) 2006-09-15 2013-05-01 Capsugel Belgium NV Rapidly disintegrating dosage form
US20080317677A1 (en) * 2007-06-22 2008-12-25 Szymczak Christopher E Laser Marked Dosage Forms
US20080317678A1 (en) * 2007-06-22 2008-12-25 Szymczak Christopher E Laser Marked Dosage Forms
US20100303735A1 (en) * 2007-08-17 2010-12-02 Bpsi Holdings, Llc. Method and arrangement for forming variable color pharmaceutical products
EP2605760B1 (en) * 2010-08-18 2017-01-11 Johnson & Johnson Consumer Inc. Tablet sleeve for improved performance
CN103039688B (zh) 2012-01-20 2016-01-06 奥驰亚客户服务公司 口腔用产品
US9854831B2 (en) 2012-01-20 2018-01-02 Altria Client Services Llc Oral product
CN102754908B (zh) 2012-01-20 2015-06-10 奥驰亚客户服务公司 口腔用烟草产品
CN102754907B (zh) * 2012-01-20 2015-06-24 奥驰亚客户服务公司 口腔用产品
CN103040090B (zh) * 2012-01-20 2016-03-30 奥驰亚客户服务公司 脱除烟草的口腔用产品
US9185931B2 (en) 2013-05-13 2015-11-17 Altria Client Services Inc. Oral product
US9839212B2 (en) 2015-04-16 2017-12-12 Bio-Lab, Inc. Multicomponent and multilayer compacted tablets
US10583089B2 (en) 2016-07-19 2020-03-10 Johnson & Johnson Consumer Inc. Tablets having discontinuous coated regions
CA3242369A1 (en) 2016-07-19 2018-01-25 Johnson & Johnson Consumer Inc. (A Delaware Corporation) Tablets having discontinuous coated regions
CN108354910A (zh) * 2018-05-17 2018-08-03 安士制药（中山）有限公司 一种西甲硅油软胶囊
WO2025193835A1 (en) * 2024-03-13 2025-09-18 Purdue Research Foundation Oxygenation systems and methods for hydroponics

Family Cites Families (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB759081A (en) 1954-04-15 1956-10-10 John Holroyd And Company Ltd Improvements relating to machines for the production of coated tablets and the like
US3185626A (en) 1963-03-06 1965-05-25 Sterling Drug Inc Tablet coating method
US3760804A (en) 1971-01-13 1973-09-25 Alza Corp Improved osmotic dispenser employing magnesium sulphate and magnesium chloride
BE794951A (fr) 1972-02-03 1973-05-29 Parke Davis & Co Conditionnement soluble dans l'eau
GB1497044A (en) 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
US4173626A (en) 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
DE2936040C2 (de) 1979-09-06 1982-05-19 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Dragierverfahren und Mittel zur Durchführung des Verfahrens, bestehend im wesentlichen aus Saccharose, wenigstens einem weiteren Zucker und Wasser
US4543370A (en) 1979-11-29 1985-09-24 Colorcon, Inc. Dry edible film coating composition, method and coating form
US4683256A (en) 1980-11-06 1987-07-28 Colorcon, Inc. Dry edible film coating composition, method and coating form
US4449983A (en) 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4576604A (en) 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
US4828841A (en) 1984-07-24 1989-05-09 Colorcon, Inc. Maltodextrin coating
US4643894A (en) 1984-07-24 1987-02-17 Colorcon, Inc. Maltodextrin coating
US4873231A (en) 1986-04-08 1989-10-10 Smith Walton J Decreasing the toxicity of an ibuprofen salt
US4802924A (en) 1986-06-19 1989-02-07 Colorcon, Inc. Coatings based on polydextrose for aqueous film coating of pharmaceutical food and confectionary products
IE58401B1 (en) 1986-06-20 1993-09-08 Elan Corp Plc Controlled absorption pharmaceutical composition
US4816262A (en) 1986-08-28 1989-03-28 Universite De Montreal Controlled release tablet
US5234099A (en) 1987-02-20 1993-08-10 Mcneil-Ppc, Inc. Coated medicaments and apparatus and methods for making same
US4820524A (en) 1987-02-20 1989-04-11 Mcneilab, Inc. Gelatin coated caplets and process for making same
US4966771A (en) 1987-02-20 1990-10-30 Mcneilab, Inc. Gelatin coated caplets and process for making same
US4867983A (en) 1987-02-20 1989-09-19 Mcneilab, Inc. Method for double dipping gelating coated caplets
CA1330886C (en) 1988-01-22 1994-07-26 Bend Research Inc. Osmotic system for delivery of dilute solutions
DE3822095A1 (de) 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
GB8820353D0 (en) 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
US4906478A (en) 1988-12-12 1990-03-06 Valentine Enterprises, Inc. Simethicone/calcium silicate composition
US4984240A (en) 1988-12-22 1991-01-08 Codex Corporation Distributed switching architecture for communication module redundancy
US4965089A (en) 1989-04-10 1990-10-23 Sauter Manufacturing Corp. Method and apparatus for the gelatin coating of caplets
NZ233403A (en) † 1989-04-28 1992-09-25 Mcneil Ppc Inc Simulated capsule-like medicament
US5146730A (en) 1989-09-20 1992-09-15 Banner Gelatin Products Corp. Film-enrobed unitary-core medicament and the like
US5275822A (en) 1989-10-19 1994-01-04 Valentine Enterprises, Inc. Defoaming composition
US5089270A (en) 1990-05-15 1992-02-18 L. Perrigo Company Capsule-shaped tablet
US5213738A (en) 1990-05-15 1993-05-25 L. Perrigo Company Method for making a capsule-shaped tablet
US5464631A (en) 1990-06-27 1995-11-07 Warner-Lambert Company Encapsulated dosage forms
US5460824A (en) 1990-06-27 1995-10-24 Warner-Lambert Company Method for the preparation of an encapsulated medicament
US5228916A (en) 1990-11-05 1993-07-20 Mcneil-Ppc, Inc. Apparatus for creating a gelatin coating
US5503673A (en) 1990-11-05 1996-04-02 Mcneil-Ppc, Inc Apparatus for dip coating product
US5436026A (en) 1990-11-05 1995-07-25 Mcneil-Ppc, Inc. Discharge and transfer system for apparatus for gelatin coating tablets
US5538125A (en) 1990-11-05 1996-07-23 Mcneil-Ppc, Inc. Indexing and feeding systems for apparatus for gelatin coating tablets
US5114720A (en) 1990-12-27 1992-05-19 American Cyanamid Company Gelatin coated tablets and method for producing same
CA2061520C (en) 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency
US5286497A (en) 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation
US5326570A (en) 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
JP3703481B2 (ja) 1992-01-17 2005-10-05 バーウィンド・ファーマスーティカル・サーヴィスィーズ・インコーポレーテッド セルロース重合体およびラクトースに基づくフィルム被覆および被覆組成物
US5427614A (en) 1992-02-14 1995-06-27 Warner-Lambert Company Starch based formulations
US5256440A (en) 1992-06-22 1993-10-26 Merck & Co., Inc. Process for producing a tablet core aperture
US5317849A (en) 1992-08-07 1994-06-07 Sauter Manufacturing Corporation Encapsulation equipment and method
US5415868A (en) 1993-06-09 1995-05-16 L. Perrigo Company Caplets with gelatin cover and process for making same
IT1264855B1 (it) 1993-06-21 1996-10-17 Zambon Spa Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
US5498255A (en) 1993-08-17 1996-03-12 Alza Corporation Osmotic device for protracted pulsatile delivery of agent
US6245350B1 (en) 1994-12-16 2001-06-12 Warner-Lambert Company Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
JP3670016B2 (ja) 1994-12-16 2005-07-13 ワーナー−ランバート・カンパニー カプレットをカプセル内に封入する方法及びかかる方法により得ることができる固体剤形
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
US6471994B1 (en) 1995-01-09 2002-10-29 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
US5824338A (en) 1996-08-19 1998-10-20 L. Perrigo Company Caplet and gelatin covering therefor
US6077539A (en) 1996-11-12 2000-06-20 Pozen, Inc. Treatment of migraine headache
US6103260A (en) 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
US6110499A (en) 1997-07-24 2000-08-29 Alza Corporation Phenytoin therapy
US5942034A (en) * 1997-07-24 1999-08-24 Bayer Corporation Apparatus for the gelatin coating of medicaments
DE19733505A1 (de) 1997-08-01 1999-02-04 Knoll Ag Schnell wirksames Analgeticum
US6365185B1 (en) 1998-03-26 2002-04-02 University Of Cincinnati Self-destructing, controlled release peroral drug delivery system
FR2781152B1 (fr) 1998-07-20 2001-07-06 Permatec Tech Ag Utilisation d'un polymere de type acrylique en tant qu'agent de desagregation
US20010055613A1 (en) 1998-10-21 2001-12-27 Beth A. Burnside Oral pulsed dose drug delivery system
US6270805B1 (en) 1998-11-06 2001-08-07 Andrx Pharmaceuticals, Inc. Two pellet controlled release formulation for water soluble drugs which contains an alkaline metal stearate
US6274162B1 (en) 2000-01-14 2001-08-14 Bpsi Holdings, Inc. Elegant film coating system
DE19964225C2 (de) 1999-12-17 2002-01-24 Henkel Kgaa Preßverfahren für mehrphasige Formkörper
US6599532B2 (en) 2000-01-13 2003-07-29 Osmotica Corp. Osmotic device containing alprazolam and an antipsychotic agent
GB0002305D0 (en) 2000-02-01 2000-03-22 Phoqus Limited Power material for electrostatic application
US20020028240A1 (en) 2000-04-17 2002-03-07 Toyohiro Sawada Timed-release compression-coated solid composition for oral administration
US7223421B2 (en) 2000-06-30 2007-05-29 Mcneil-Ppc, Inc. Teste masked pharmaceutical particles
US20030086972A1 (en) 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
GB0027471D0 (en) 2000-11-08 2000-12-27 Smithkline Beecham Plc Processes
US6872405B2 (en) 2001-05-10 2005-03-29 Yamanouchi Pharmaceutical Co., Ltd. Quick-disintegrating tablet in buccal cavity and manufacturing method thereof
US20030072731A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing starch or dextrin
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
GB0120835D0 (en) 2001-08-28 2001-10-17 Smithkline Beecham Plc Process
KR20040041586A (ko) 2001-08-30 2004-05-17 가부시키가이샤산와카가쿠켄큐쇼 성형품의 제조장치 및 그 장치에 의해 제조가능한 성형품
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US6837696B2 (en) 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US6742646B2 (en) 2001-09-28 2004-06-01 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US20040253312A1 (en) 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
NZ532096A (en) 2001-09-28 2006-10-27 Mcneil Ppc Inc Dosage forms having an inner core and outer shell with different shapes
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US6767200B2 (en) 2001-09-28 2004-07-27 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US6946156B2 (en) 2002-05-15 2005-09-20 Mcneil-Ppc, Inc. Process for enrobing a core
US7169450B2 (en) 2002-05-15 2007-01-30 Mcneil-Ppc, Inc. Enrobed core
US7429619B2 (en) 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
JP2006518388A (ja) 2003-02-20 2006-08-10 ビーピーエスアイ ホールディングス，インコーポレーテッド 真珠光沢フィルムコーティング剤システム及びそれによりコーティングされた基材
US7879354B2 (en) * 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US8067029B2 (en) 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets

Also Published As

Publication number Publication date
HK1135615A1 (en) 2010-06-11
KR101140599B1 (ko) 2012-07-09
EP2098224B2 (en) 2021-08-18
CN1913877B (zh) 2012-07-18
US20050152971A1 (en) 2005-07-14
DE602005014874D1 (de) 2009-07-23
CN1913877A (zh) 2007-02-14
MXPA06008307A (es) 2007-01-18
EP1773302A1 (en) 2007-04-18
ES2326671T3 (es) 2009-10-16
EP2098224A1 (en) 2009-09-09
DK1773302T3 (da) 2009-09-14
ES2420843T5 (es) 2022-03-04
KR20070036781A (ko) 2007-04-03
EP2098224B1 (en) 2013-05-29
CA2553444C (en) 2013-09-24
EP1773302B1 (en) 2009-06-10
ES2420843T3 (es) 2013-08-27
BRPI0513702B8 (pt) 2022-08-30
EP1773302B2 (en) 2024-06-26
ATE433319T1 (de) 2009-06-15
PL1773302T3 (pl) 2009-11-30
RU2007102286A (ru) 2008-07-27
WO2006022805A1 (en) 2006-03-02
RU2367413C2 (ru) 2009-09-20
US8067029B2 (en) 2011-11-29
BRPI0513702B1 (pt) 2020-02-18
CA2553444A1 (en) 2006-03-02

Similar Documents

Publication Publication Date Title
BRPI0513702A (pt) comprimidos revestidos gelatinosos que se desintegram rapidamente
AR058819A1 (es) Colorantes que difractan la radiacion
CL2007003497A1 (es) Producto de cuidado oral que comprende una primera composicion que contiene una sal de calcio insoluble que no es una sal de fosfato de calcio y una segunda composicion que comprende una fuente de iones fosfato; y uso para el blanqueamiento de los di
AR058753A1 (es) Uso de composiciones nutricionales con fosfolipidos esfingolipidos y colesterol
ATE493081T1 (de) Faserverstärktes verbundmaterial
AR050254A1 (es) Intermediarios y procesos para preparar dichos intermediarios utiles en la fabricacion de pirrolotriazinas
BRPI0510777A (pt) indazóis substituìdos, composições que os contêm, processo de produção e utilização
NI200900022A (es) Anticuerpo especifico de prlr y usos del mismo
TNSN08071A1 (en) Solid dosage forms of valsartan and amlodipine and method of making the same
BRPI0512477A (pt) processos para a fabricação de uma polpa de meta- e para-aramida, polpa de meta- e para-aramida, material de fricção e material de vedação
CL2007002620A1 (es) Compuesto marcado con isotopo de fluor; metodo para preparar dicho compuesto; composicion que comprende dicho compuesto; metodo de tomar imagenes de enfermedades que comprende el compuesto antes mencionado; kit que comprende dicho compuesto.
AR066527A1 (es) Panel para la contruccion de edificios con salientes perpendiculares a una cara
BRPI0505355A (pt) toner que inclui poliéster amorfo, poliéster reticulado e poliéster cristalino
CL2004001473A1 (es) Procedimiento para producir neuronas desde celulas mesenquimatosas no diferenciadas y composicion que las contiene.
BRPI0508278A (pt) recipiente possuindo indìcios irradiados
MA31698B1 (fr) Caisse montable, demontable et reutilisable
BRPI0719491A2 (pt) "método de seleção de uma formulação de cor não volátil para manufatura, arranjo para a seleção de uma formulação de cor não volátil para a manufatira, método para a manufatura de uma formulação de cor para ser utilizada na maufatura de uma peça que compreende um material polimérico, método para a produção de um material reciclado em uma cor desejadae método para a manufatura de um peça que compreende um material polimérico em uma cor predeterminada"
BRPI0508344A (pt) objeto multicamada sintético
MX280211B (es) Polimero, un metodo para producir el polimero y una mezcla de cemento que utiliza el mismo.
BRPI0914170B8 (pt) recipiente para produtos medicinais e processo para a produção do mesmo
AR051941A1 (es) Formas de dosificacion que tienen una superficie con microrelieves y metodos y aparato para su producion
BRPI0520799A2 (pt) método de produção de elementos decorativos, particularmente insìgnias
BRPI0717943A2 (pt) Composição farmacêutica; forma de dosagem farmacêutica; processo para a preparação de uma composição farmacêutica; e produto preparado pelo processo
CL2008001746A1 (es) Proceso para la fabricacion de arilmetilsulfonilarenos que comprende hacer reaccionar un arilmetilhaluro con un arilsulfinato de sodio en presencia de una base opcionalmente en presencia de un disolvente; y proceso para la fabricacion de un ligando 3
DE602005009651D1 (de) Hartgelatinekapsel mit verbesserter Filmstärke

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 18/02/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/02/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B25G Requested change of headquarter approved

Owner name: MCNEIL-PPC, INC. (US)

B25D Requested change of name of applicant approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

B25A Requested transfer of rights approved

Owner name: CHENANGO ZERO LLC (US)

B25A Requested transfer of rights approved

Owner name: CHENANGO TWO LLC (US)

B25A Requested transfer of rights approved

Owner name: CURRAHEE HOLDING COMPANY INC. (US)

B25D Requested change of name of applicant approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

B25A Requested transfer of rights approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

B25K Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: republication

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

Free format text: RETIFICACAO DO DESPACHO 25.1 PUBLICADO NA RPI 2775 DE 12/03/2024.ONDE SE LE: ?EM ATENDIMENTO AO SOLICITADO NA PETICAO 870230115237 DE 29/12/2023 (...)?LEIA-SE: ?EM ATENDIMENTO AO SOLICITADO NA PETICAO 870230115587 DE 29/12/2023 (...)?

B25D Requested change of name of applicant approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

B25G Requested change of headquarter approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

B25D Requested change of name of applicant approved

Owner name: KENVUE BRANDS LLC (US)